Precision performance at low levels and 99th percentile concentration of the Access® AccuTnI® assay on two different platforms

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 3, 2009, Pages 367-371

  Zaninotto, Martina ^a   Mion, Monica Maria ^a   Novello, Enrica ^a   Moretti, Marco ^b   Delprete, Ernesto ^b   Rocchi, Marco Bruno ^c   Sisti, Davide ^c   Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

Author keywords

Analytical precision; Cardiac troponin I (cTnI); CTnI 99th percentile concentration; Myocardial necrosis; Reference population

Indexed keywords

TROPONIN I;

ADULT; AGED; ARTICLE; AUTOANALYZER; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 63849116463     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.080     Document Type: Article

References (12)

1. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
3. NCCLS. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS document EP5-A. Wayne, PA: NCCLS, 1999.
4. Sasse EA. How to define and determine reference intervals in the clinical laboratory. NCCLS document C28-A, 2nd ed. Wayne, PA: NCCLS, 2002.
5. Manly BF. Randomization, bootstrap and Monte Carlo methods in biology. London: Chapman and Hall, 1997.
6. Kavsak P, Lustig V, MacRae AR. Clinical evaluation of the Beckman Coulter AccuTnI assay for the early detection of acute myocardial infarction. Clin Chem 2004;50(Suppl 6):A5.
7. Venge P, Lindahl B, Wallentin L. New generation cardiac troponin I assay for the Access immunoassay system. Clin Chem 2001;47:959-61.
8. Shaeskin DJ. Handbook of parametric and non parametric statistical procedures, 2nd ed. London: Chapman and Hall/CRC, 2000.
9. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007;53:1558-60.
10. Apple FS, Murakami MM. Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin Chem 2004;50:1477-9.
11. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003;49:1331-6.
12. Prontera C, Fortunato A, Storti S, Mercuri A, Longobardo G, Zucchelli GC, et al. Evaluation of analytical performance of the Siemens ADVIA TnI Ultra immunoassay. Clin Chem 2007;53:1722-3.